Vivos Therapeutics Inc is a medical technology company... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
VVOS is expected to report earnings to fall 38.46% to -31 cents per share on November 18
Q3'26
Est.
$-0.32
Q1'26
Missed
by $0.07
Q4'25
Missed
by $0.08
Q3'25
Missed
by $0.01
Q2'25
Missed
by $0.16
The last earnings report on May 20 showed earnings per share of -51 cents, missing the estimate of -44 cents. With 5.54M shares outstanding, the current market capitalization sits at 3.36M.